TY - JOUR AU - Verna, E. C. AU - Brown, R. S. PY - 2006 DA - 2006// TI - Hepatitis C virus and liver transplantation JO - Clin Liver Dis VL - 10 UR - https://doi.org/10.1016/j.cld.2006.08.012 DO - 10.1016/j.cld.2006.08.012 ID - Verna2006 ER - TY - STD TI - Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology, 2004;39(4):1147–71. ID - ref2 ER - TY - JOUR AU - Awad, T. AU - Thorlund, K. AU - Hauser, G. AU - Stimac, D. AU - Mabrouk, M. AU - Gluud, C. PY - 2010 DA - 2010// TI - Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials JO - Hepatology VL - 51 UR - https://doi.org/10.1002/hep.23504 DO - 10.1002/hep.23504 ID - Awad2010 ER - TY - JOUR AU - Averhoff, F. M. AU - Glass, N. AU - Holtzman, D. PY - 2012 DA - 2012// TI - Global burden of hepatitis C: considerations for healthcare providers in the United States JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis361 DO - 10.1093/cid/cis361 ID - Averhoff2012 ER - TY - JOUR AU - Chen, S. L. AU - Morgan, T. R. PY - 2006 DA - 2006// TI - The natural history of hepatitis C virus (HCV) infection JO - Int J Med Sci VL - 3 UR - https://doi.org/10.7150/ijms.3.47 DO - 10.7150/ijms.3.47 ID - Chen2006 ER - TY - JOUR AU - Sullivan, S. D. AU - Jensen, M. AU - Bernstein, D. E. AU - Hassanein, T. I. AU - Foster, G. R. AU - Lee, S. S. AU - Cheinquer, H. AU - Craxi, A. AU - Cooksley, G. AU - Klaskala, W. AU - Perttit, K. AU - Patel, K. K. AU - Green, J. PY - 2004 DA - 2004// TI - Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C JO - Am J Gastroenterol VL - 99 UR - https://doi.org/10.1111/j.1572-0241.2004.30286.x DO - 10.1111/j.1572-0241.2004.30286.x ID - Sullivan2004 ER - TY - STD TI - Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology. 2006;43(6):1303–10. ID - ref7 ER - TY - STD TI - Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335–74. ID - ref8 ER - TY - STD TI - Petta S, Cabibbo G, Enea M, Macaluso FS, Plaia A, Bruno R, et al. Cost-Effectiveness of Sofosbuvir-Based Triple Therapy for Untreated Patients with Genotype 1 Chronic Hepatitis C. Hepatology. 2014;59(5):1692–705. ID - ref9 ER - TY - STD TI - Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011;364(25):2405–16. ID - ref10 ER - TY - STD TI - Tucker M. FDA approves 'game changer' hepatitis C drug Sofosbuvir". Medscape. December 6, 2013. http://www.medscape.com/viewarticle/817371 (accessed 1 March 2015). UR - http://www.medscape.com/viewarticle/817371 ID - ref11 ER - TY - STD TI - Ledipasvir-Sofosbuvir (Harvoni). Hepatitis C Online. http://www.hepatitisc.uw.edu/page/ledipasvir-sofosbuvir (accessed 1 Mar 2015). UR - http://www.hepatitisc.uw.edu/page/treatment/drugs/ledipasvir-sofosbuvir ID - ref12 ER - TY - STD TI - Simeprevir (Olysio). Hepatitis C Online. http://www.hepatitisc.uw.edu/page/treatment/drugs/simeprevir-drug (accessed 1 Mar 2015). UR - http://www.hepatitisc.uw.edu/page/treatment/drugs/simeprevir-drug ID - ref13 ER - TY - STD TI - Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir (Viekira Pak). Hepatitis C Online. http://www.hepatitisc.uw.edu/page/treatment/drugs/3d (accessed 1 Mar 2015). UR - http://www.hepatitisc.uw.edu/page/treatment/drugs/3d ID - ref14 ER - TY - JOUR AU - Salomon, J. A. AU - Weinstein, M. C. AU - Hammitt, J. K. PY - 2003 DA - 2003// TI - Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.2.228 DO - 10.1001/jama.290.2.228 ID - Salomon2003 ER - TY - JOUR AU - Jacobson, I. M. AU - Gordon, S. C. AU - Kowdley, K. V. AU - Yoshida, E. M. AU - Rodriguez-Torres, M. AU - Sulkowski, M. S. AU - Shiffman, M. L. AU - Lawitz, E. AU - Everson, G. AU - Bennett, M. AU - Schiff, E. AU - Al-Assi, M. T. AU - Subramanian, G. M. AU - An, D. AU - Lin, M. AU - McNally, J. AU - Brainard, D. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Patel, K. AU - Feld, J. AU - Pianko, S. AU - Nelson, D. R. PY - 2013 DA - 2013// TI - Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214854 DO - 10.1056/NEJMoa1214854 ID - Jacobson2013 ER - TY - JOUR AU - Lawitz, E. AU - Mangia, A. AU - Wyles, D. AU - Rodriguez-Torres, M. AU - Hassanein, T. AU - Gordon, S. C. AU - Schultz, M. AU - Davis, M. N. AU - Kayali, Z. AU - Reddy, K. R. AU - Jacobson, I. M. AU - Kowdley, K. V. AU - Nyberg, L. AU - Subramanian, G. M. AU - Hyland, R. H. AU - Arterburn, S. AU - Jiang, D. AU - McNally, J. AU - Brainard, D. AU - Symonds, W. T. AU - McHutchison, J. G. AU - Sheikh, A. M. AU - Younossi, Z. AU - Gane, E. J. PY - 2013 DA - 2013// TI - Sofosbuvir for previously untreated chronic hepatitis C infection JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214853 DO - 10.1056/NEJMoa1214853 ID - Lawitz2013 ER - TY - STD TI - Sovaldi drug description. www.rxlist.com/sovaldi-drug.htm. (accessed 1 Mar 2015). UR - http://www.rxlist.com/sovaldi-drug.htm ID - ref18 ER - TY - STD TI - 7U.S. Food and Drug Administration Approves Gilead’s Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C. Gilead [eLetter] 6 December 2013. www.gilead.com/news/press-releases/2013/12/us-food-and-drug-administration-approves-gileads-sovaldi-sofosbuvir-for-the-treatment-of-chronic-hepatitis-c#sthash.T9uTbSWK.dpuf". (accessed 1 March 2015). UR - http://www.gilead.com/news/press-releases/2013/12/us-food-and-drug-administration-approves-gileads-sovaldi-sofosbuvir-for-the-treatment-of-chronic-hepatitis-c#sthash.T9uTbSWK.dpuf ID - ref19 ER - TY - STD TI - Peginterferon alfa-2a (Pegasys). Hepatitis C Online. www.hepatitisc.uw.edu/page/treatment/drugs/peginterferon-alfa-drug. (accessed 1 March 2015). UR - http://www.hepatitisc.uw.edu/page/treatment/drugs/peginterferon-alfa-drug ID - ref20 ER - TY - JOUR AU - Liu, S. AU - Watcha, D. AU - Holodniy, M. AU - Goldhaber-Fiebert, J. PY - 2014 DA - 2014// TI - Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations JO - Ann Intern Med VL - 161 UR - https://doi.org/10.7326/M14-0602 DO - 10.7326/M14-0602 ID - Liu2014 ER - TY - JOUR AU - Bennett, W. G. AU - Inoue, Y. AU - Beck, J. R. AU - Wong, J. B. AU - Pauker, S. G. AU - Davis, G. L. PY - 1997 DA - 1997// TI - Estimates of the cost-effective of a single course of interferon-alpha2b in patients with histologically mild chronic hepatitis C JO - Ann Intern Med VL - 127 UR - https://doi.org/10.7326/0003-4819-127-10-199711150-00001 DO - 10.7326/0003-4819-127-10-199711150-00001 ID - Bennett1997 ER - TY - JOUR AU - Davis, G. L. AU - Alter, M. J. AU - El-Serag, H. AU - Poynard, R. AU - Jennings, L. W. PY - 2010 DA - 2010// TI - Aging of the hepatitis C virus infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression JO - Gastroenterology VL - 138 UR - https://doi.org/10.1053/j.gastro.2009.09.067 DO - 10.1053/j.gastro.2009.09.067 ID - Davis2010 ER - TY - JOUR AU - Kim, W. R. AU - Poterucha, J. J. AU - Hermans, J. E. AU - Therneau, T. M. AU - Dickson, E. R. AU - Evans, R. W. AU - Gross, J. B. PY - 1997 DA - 1997// TI - Cost-effectiveness of 6 and 48 weeks of interferon-alpha therapy for chronic hepatitis C JO - Ann Intern Med VL - 127 UR - https://doi.org/10.7326/0003-4819-127-10-199711150-00002 DO - 10.7326/0003-4819-127-10-199711150-00002 ID - Kim1997 ER - TY - JOUR AU - Younossi, Z. AU - Singer, M. AU - Mchutchison, J. AU - Shermock, K. PY - 1999 DA - 1999// TI - Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C JO - Hepatology VL - 30 UR - https://doi.org/10.1002/hep.510300518 DO - 10.1002/hep.510300518 ID - Younossi1999 ER - TY - STD TI - E Arias. United States Life Tables, 2008. National Vital Statistics Reports. 2012;61. www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_10.pdf. (accesses 1 March 2015). UR - http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_10.pdf ID - ref26 ER - TY - JOUR AU - Younossi, Z. AU - McCormick, M. AU - Boparai, N. AU - Price, L. AU - Fqrquhar, L. AU - Guyatt, G. PY - 1999 DA - 1999// TI - Assessment of utilities and health-related quality of life in patients with chronic liver disease JO - Gatroenterology VL - 116 ID - Younossi1999 ER - TY - STD TI - Bureau of Labor Statistics. http://data.bls.gov/timeseries/CUUR0000SAM?output_view=pct_12mths (accessed 1 Mar 2015). UR - http://data.bls.gov/timeseries/CUUR0000SAM?output_view=pct_12mths ID - ref28 ER - TY - JOUR AU - Fattovich, G. AU - Guistina, G. AU - Degas, E. PY - 1997 DA - 1997// TI - Morbidity and mortality in compensated cirrhosis type C: a retrospective follow up study of 384 patients JO - Gastroenterology VL - 112 UR - https://doi.org/10.1053/gast.1997.v112.pm9024300 DO - 10.1053/gast.1997.v112.pm9024300 ID - Fattovich1997 ER - TY - JOUR AU - Degos, F. AU - Christidis, C. AU - Ganne-Carrie, N. AU - Farmachidi, J. P. AU - Degott, C. AU - Guettier, C. AU - Trinchet, J. C. AU - Beaugrand, M. AU - Chevret, S. PY - 2000 DA - 2000// TI - Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death JO - Gut VL - 47 UR - https://doi.org/10.1136/gut.47.1.131 DO - 10.1136/gut.47.1.131 ID - Degos2000 ER - TY - JOUR AU - Fattovich, G. AU - Stroffolini, T. AU - Zagni, I. AU - Donato, F. PY - 2004 DA - 2004// TI - Hepatocellular carcinoma in cirrhosis: incidence and risk factors JO - Gastroenterology VL - 127 UR - https://doi.org/10.1053/j.gastro.2004.09.014 DO - 10.1053/j.gastro.2004.09.014 ID - Fattovich2004 ER - TY - JOUR AU - Forman, L. M. AU - Lewis, J. D. AU - Berlin, J. A. AU - Feldman, H. I. AU - Lucey, M. R. PY - 2002 DA - 2002// TI - The association between hepatitis C infection and survival after orthotopic liver transplantation JO - Gastroenterology VL - 122 UR - https://doi.org/10.1053/gast.2002.32418 DO - 10.1053/gast.2002.32418 ID - Forman2002 ER -